 Connection
Elaine Morrato to Missouri
This is a "connection" page, showing publications Elaine Morrato has written about Missouri.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.930 |
|
|
|
-
Morrato EH, Campagna EJ, Brewer SE, Dickinson LM, Thomas DS, Miller BF, Dearing J, Druss BG, Lindrooth RC. Metabolic Testing for Adults in a State Medicaid Program Receiving Antipsychotics: Remaining Barriers to Achieving Population Health Prevention Goals. JAMA Psychiatry. 2016 Jul 01; 73(7):721-30.
Score: 0.135
-
Morrato EH, Brewer SE, Campagna EJ, Dickinson LM, Thomas DS, Druss BG, Miller BF, Newcomer JW, Lindrooth RC. Glucose Testing for Adults Receiving Medicaid and Antipsychotics: A Population-Based Prescriber Survey on Behaviors, Attitudes, and Barriers. Psychiatr Serv. 2016 07 01; 67(7):798-802.
Score: 0.133
-
Nicol GE, Campagna EJ, Garfield LD, Newcomer JW, Parks JJ, Morrato EH. The Role of Clinical Setting and Management Approach in Metabolic Testing Among Youths and Adults Treated With Antipsychotics. Psychiatr Serv. 2016 Jan; 67(1):128-32.
Score: 0.128
-
Morrato EH, Parks J, Campagna EJ, Muser E, Thomas DS, Fang H, Doshi D. Comparative effectiveness of injectable paliperidone palmitate versus oral atypical antipsychotics: early postmarketing evidence. J Comp Eff Res. 2015 Mar; 4(2):89-99.
Score: 0.120
-
Root ED, Thomas DS, Campagna EJ, Morrato EH. Adjusting for geographic variation in observational comparative effectiveness studies: a case study of antipsychotics using state Medicaid data. BMC Health Serv Res. 2014 Aug 27; 14:355.
Score: 0.119
-
Campagna EJ, Muser E, Parks J, Morrato EH. Methodological considerations in estimating adherence and persistence for a long-acting injectable medication. J Manag Care Spec Pharm. 2014 Jul; 20(7):756-66.
Score: 0.118
-
Morrato EH, Druss BG, Hartung DM, Valuck RJ, Thomas D, Allen R, Campagna E, Newcomer JW. Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users. Pharmacoepidemiol Drug Saf. 2011 Jan; 20(1):66-75.
Score: 0.092
-
Morrato EH, Druss B, Hartung DM, Valuck RJ, Allen R, Campagna E, Newcomer JW. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. Arch Gen Psychiatry. 2010 Jan; 67(1):17-24.
Score: 0.086
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|